Jonathan Lischalk MD (He/Him)
Central Nervous System Cancer, Thoracic Cancer, Urologic Cancer
Medical Director of NYU Langone CyberKnife Center; Clinical Assistant Professor of Radiation Oncology; Director of Research, Department of Radiation Oncology
Join to View Full Profile
3800 Reservoir Rd NW Dept ofWashington, DC 20007
Phone+1 202-444-3320
Fax+1 202-444-3786
Dr. Lischalk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan W. Lischalk is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including NYU Winthrop Hospital and MedStar Georgetown University Hospital. He received his medical degree from University of Washington School of Medicine and has been in practice 10 years. As the medical director of NYCyberKnife at Perlmutter Cancer Center—Manhattan, he specializes in managing prostate, lung, brain, and spine cancer using CyberKnife® radiosurgery. He has more than 20 publications and 22 citings.
Education & Training
MedStar Health Georgetown UniversityResidency, Radiation Oncology, 2013 - 2017
Stamford Hospital/Columbia University College of Physicians and SurgeonsInternship, Internal Medicine, 2012 - 2013
University of Washington School of MedicineClass of 2012
Certifications & Licensure
DC State Medical License 2017 - 2027
NY State Medical License 2020 - 2026
VA State Medical License 2016 - 2026
MD State Medical License 2017 - 2022
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- November 2020: Top Doctors Washingtonian Magazine, 2020
- String of Pearls Nominee for Outstanding Medical Student Teaching Georgetown University School of Medicine, 2016
Publications & Presentations
PubMed
- Screening Colonoscopy Association With Gastrointestinal Toxicity and Quality of Life After Prostate Stereotactic Body Radiation Therapy.Jonathan W Lischalk, Vianca F Santos, Brianna Vizcaino, Astrid Sanchez, Christopher Mendez
Advances in Radiation Oncology. 2025-05-01 - Fractionated robotic radiosurgery for unfavorable nonfunctioning pituitary macroadenoma: 5-year outcomes from a single institution protocol.Akrita Bhatnagar, Monica Pernia Marin, Jonathan W Lischalk, Min Ji Koh, Siviero Agazzi
Frontiers in Oncology. 2025-01-01 - 1 citationsFractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome and prognostic factors.Anna Krämer, Laura Hahnemann, Fabian Schunn, Christoph A Grott, Michael Thomas
Clinical and Translational Radiation Oncology. 2025-01-01
Press Mentions
Study Aims to Genetically & Radiologically Personalize Prostate Cancer Treatment with Two Doses of RadiationSeptember 13th, 2023
Professional Memberships
- Member
- Member
External Links
- ORCID Public Recordhttps://orcid.org/0000-0002-3714-7757
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
